How Hyperlocal Dynamics Are Redefining Market Access

Eddie Vogel, Ph.D. | Vice President, Consulting
Greg Gregory, Ph.D. | Executive Vice President, Partner  

Access strategy has long followed a familiar playbook: secure coverage, reduce utilization management, optimize benefit design, and focus on pull‑through. When those boxes were checked, success was supposed to follow. Increasingly, it doesn’t.  

That disconnect came up repeatedly in conversations last week at Asembia, often not in formal sessions, but in exchanges among access leaders comparing notes between sessions and over team dinners. Different products, different categories, but the same frustration: strong national coverage paired with inconsistent local performance.

Prescriptions are written but not filled. Time‑to‑therapy stretches. Volume swings dramatically by geography, even with a similar payer mix. On paper, access looks solid. In practice, it breaks.

What’s driving that gap is a deeper structural shift in where access decisions are actually made. Access is becoming hyperlocalized, shaped less by national policy and more by local systems, workflows, incentives, and operational realities closer to the point of care.

In 2026, access is increasingly decided (and denied) below the payer policy layer, where local incentives, workflow, contracting, and operational realities determine what actually happens to a prescription.

The Hyperlocalization of Access: What It Is (and Why It’s Happening) 

For years, access strategy has been largely payer‑centric. That still matters, but it’s no longer sufficient.

Does this sound familiar? You’ve launched (or relaunched) a product with what looks like a strong access story:

• 90% covered lives
• Light UM
• Copay support in place
• Engaged field team
• Clear demand

And yet, performance doesn’t follow:

• TRx grows but NRx plateaus
• Written Rxs don’t reliably convert to fills
• Abandonment persists
• Time‑to‑therapy stretches
• Volume varies dramatically by geography, even with a similar payer mix

So, teams do what they’ve always done: validate coverage data, revisit copay, review SP performance, pressure‑test PA turnaround, and refresh messaging.

But often, the issue is local access friction, and it’s increasingly concentrated in two places: IDNs/health systems and employers.

This shift is accelerating due to:

• Provider consolidation and standardization, with enterprise pathways and order sets
• Rising operational complexity in specialty care
• Employers acting as purchasers, reshaping care before a claim ever hits

This results in a product that can be approved on paper but blocked in practice, without any change to payer policy.

Where Access Gets Lost

IDN / Health System Risks 

Within IDNs and health systems, access often comes down to whether a product is easy to operationalize, economically viable, and embedded in workflow.

Key friction points include:

• Pathways and standardization. Coverage doesn’t guarantee preferred status. Enterprise pathways, decision support tools, and committee decisions can steer utilization elsewhere.
• EHR reality. If a product isn’t built into order sets, smart plans, and diagnostic workflows — or doesn’t align cleanly with routing, coding, and documentation — it won’t scale. The EHR has become the de facto local formulary.
• Operational models. Even pharmacy‑benefit products are shaped by specialty pharmacy routing, MID policies (where allowed within broader specialty distribution strategy), internal capture priorities, and site‑of‑care economics.
• Local economics. Systems assess staff burden, denial risk, margin alignment, and (where applicable) 340B strategy. Products perceived as operationally “expensive” tend to lose traction.
• Fragmented ownership. No single stakeholder owns access. Pharmacy, clinicians, revenue cycle, IT, specialty pharmacy, and administrators all influence outcomes requiring orchestration, not just a clinical pitch.

Employer Risks 

If IDNs are about workflow and systems, employers are about ROI, navigation, and benefit architecture, often upstream of prescribing.

Common employer‑driven risks include:

• Pre‑claim steering. Navigation programs, condition management, COEs, digital triage, and specialty carve‑outs can redirect patients before therapy initiation.
• Benefit design friction. High deductibles, accumulators, specialty tiering, mandatory SP channels, or employer‑specific edits mean “covered” doesn’t always mean “accessible.”
• Direct contracting and COEs. Employers increasingly shape care via bundled arrangements and preferred networks that standardize protocols locally.
• A different value lens. Employers expect faster ROI, clearer cost offsets, predictability, and measurable outcomes, requiring evidence to translate into operational value.

What to Do Differently: Three Actions to Win in a Hyperlocalized World 

Teams making progress are strategizing differently to ensure momentum.

1. Build a cohesive strategy aligned to how local decisions are made

Access plays out across three arenas:

• Payer policy
• Provider systems (pathways, EHR, operations, economics)
• Employers (benefits, navigation, direct contracting)

Winning requires mapping local decision drivers via customer segmentation, identifying the true gatekeepers, and defining what “success” looks like locally: preferred pathway status, EHR embeddedness, faster time‑to‑therapy, and lower abandonment. A winning strategy shifts the focus from “Do we have coverage?” to “Are we positioned to be chosen and executed locally?”

2. Deploy tactics that resonate with hyperlocal stakeholders

The most effective tactics solve local problems.

• For IDNs, that often includes pathway strategy, GPO or system‑level contracting, EHR build support, and operational pull‑through that reduces staff burden.
• For employers, it may involve direct contracting, COE alignment, benefit and navigation engagement, and reframing value in terms of predictability, outcomes, and total cost of care.

One national value story rarely travels intact. Winning requires a value story that can flex, one that lands differently with payers, systems, and employers.

3. Re‑target and re‑tool the field for local value delivery

Hyperlocal access is won in execution. That means targeting based on where friction is greatest and enabling teams to address pathway barriers, EHR gaps, and employer dynamics.

Clear role definition across account management, market access, medical, IT/EHR expertise, and employer‑facing capabilities is essential. So is enablement that matches the ask: committee‑ready materials, localized evidence, stakeholder maps, and metrics that track local progress.

Turning National Access into Local Performance 

Access is increasingly decided (and just as often denied) inside health systems, within EHR workflows, across employer benefit designs, and through local operational economics.

For teams seeing strong coverage but uneven performance, this signals that the access model needs to evolve. Winning in a hyperlocalized access environment requires a different posture: strategy aligned to how local decisions are made, tactics that solve real operational friction, and execution designed to deliver value where access breaks down.

If these challenges sound familiar, schedule a meeting with our team to explore how Precision AQ helps organizations identify where access breaks down, align strategy to local decision drivers, and translate national wins into on-the-ground performance.